NINDS Neuroscience Funding Announcements

Skip secondary menu

New Information from NINDS Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.



R21 Grants for Alzheimer's Disease Drug Discovery
Release Date: November 24, 2004
Announcement Number: PAS-05-022
Application Receipt Date:
February 1, 2005
June 1, 2005
February 1, 2005
February 1, 2006
May 1, 2006
   

Funding Contact: Diane DiEuliisPh.D.
Program Area: Neurodegeneration

Brief Description:
In 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer's Disease (AD) Prevention Initiative. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This Program Announcement (PA) focuses on AD drug discovery while a companion PA is targeted to AD pilot clinical trials.

Choose an option to view additional funding announcements
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives